BDBM323222 N-[(R)-1-(3,4-dichlorobenzyl)-2-oxo-2-(3-pentyl-3-phenylazetidin-1-yl)ethyl]-3-(1H-imidazol-4-yl)propionamide::US9630949, 52

SMILES CCCCCC1(CN(C1)C(=O)[C@@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)CCc1c[nH]cn1)c1ccccc1

InChI Key InChIKey=BRRBGZGHXHJKBS-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 323222   

TargetMelanocortin receptor 4(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM323222(N-[(R)-1-(3,4-dichlorobenzyl)-2-oxo-2-(3-pentyl-3-...)
Affinity DataEC50:  250nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM323222(N-[(R)-1-(3,4-dichlorobenzyl)-2-oxo-2-(3-pentyl-3-...)
Affinity DataEC50:  2.00E+3nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent